Company revises adjusted EBITDA outlook to $64M-$68M for 2026 amid ventilation growth and business expansion.
Viemed Healthcare (VMD) outlined a 2026 revenue outlook of $314M to $320M during its Q2 2026 earnings call. The company also revised its adjusted EBITDA guidance to a range of $64M to $68M, citing accelerated ventilation growth and broader platform expansion as key drivers.
Management highlighted renewed momentum in its core ventilation segment alongside continued business diversification. The revised outlook follows a quarter where the company emphasized operational growth and strategic initiatives to strengthen its market position.
No immediate market reaction was detailed in the source, though the updated guidance reflects confidence in sustained performance through 2026.